SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-132419
Filing Date
2020-05-04
Accepted
2020-05-04 16:21:42
Documents
10
Period of Report
2020-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d898684d8k.htm 8-K 21266
2 EX-10.1 d898684dex101.htm EX-10.1 29163
3 EX-10.2 d898684dex102.htm EX-10.2 29341
4 EX-10.3 d898684dex103.htm EX-10.3 29406
5 EX-10.4 d898684dex104.htm EX-10.4 29495
6 GRAPHIC g898684g0501231422476.jpg GRAPHIC 1824
7 GRAPHIC g898684g0501232233468.jpg GRAPHIC 1824
8 GRAPHIC g898684g0501232233592.jpg GRAPHIC 1734
9 GRAPHIC g898684g0501232507880.jpg GRAPHIC 1824
10 GRAPHIC g898684g0501232508068.jpg GRAPHIC 1734
  Complete submission text file 0001193125-20-132419.txt   153027
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 20845160
SIC: 2834 Pharmaceutical Preparations